Petros Pharmaceuticals PTPI Stock
$0.01
0.000000%
Add to favorites
SECTOR
COUNTRY
Exchange
Market Cap
$254.23K
LOW - HIGH [24H]
$0.01
-
$0.01
VOLUME [24H]
$202.01K
P/E Ratio
0.0041
Earnings per share
$1.43
ISIN
US71678J3086
Petros Pharmaceuticals Price Chart
Petros Pharmaceuticals PTPI Financial and Trading Overview
| Petros Pharmaceuticals stock price | 0.0060 USD |
| Previous Close | 0.0058 USD |
| Open | 0.0058 USD |
| Bid | 0.0058 USD x 2990800 |
| Ask | 0.0072 USD x 2508300 |
| Day's Range | 0.0055 - 0.0058 USD |
| 52 Week Range | 0.002 - 0.03 USD |
| Volume | 202.01K USD |
| Avg. Volume | 112.65K USD |
| Market Cap | 233.05K USD |
| Beta (5Y Monthly) | 1.958 |
| PE Ratio (TTM) | 0.003846154 |
| EPS (TTM) | 1.43 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PTPI Valuation Measures
| Enterprise Value | -3225885 USD |
| Trailing P/E | 0.003846154 |
| Forward P/E | -0.0050458713 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.3235294 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Petros Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.958 |
| 52-Week Change | -78.57% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 0.002 USD |
| 50-Day Moving Average | 0.00426 USD |
| 200-Day Moving Average | 0.006835 USD |
PTPI Share Statistics
| Avg. Volume (3 month) | 112.65K USD |
| Avg. Daily Volume (10-Days) | 96.08K USD |
| Shares Outstanding | 42.37M |
| Float | 28.93M |
| Short Ratio | 0.17 |
| % Held by Insiders | 25.58% |
| % Held by Institutions | 10.23% |
| Shares Short | 493.83K |
| Short % of Float | 25.06% |
| Short % of Shares Outstanding | 24.05% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.81% |
| Return on Equity (ttm) | -124.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -17358040 USD |
| Diluted EPS (ttm) | 1.43 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.49M USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.246 |
| Book Value Per Share (mrq) | 0.017 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3715595 USD |
| Levered Free Cash Flow (ttm) | -1822107 USD |
Profile of Petros Pharmaceuticals
| Country | United States |
| State | NY |
| City | New York |
| Address | 1185 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 973 242 0005 |
| Website | https://petrospharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Q&A For Petros Pharmaceuticals Stock
What is a current PTPI stock price?
Petros Pharmaceuticals PTPI stock price today per share is 0.0060 USD.
How to purchase Petros Pharmaceuticals stock?
You can buy PTPI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Petros Pharmaceuticals?
The stock symbol or ticker of Petros Pharmaceuticals is PTPI.
Which industry does the Petros Pharmaceuticals company belong to?
The Petros Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Petros Pharmaceuticals have in circulation?
The max supply of Petros Pharmaceuticals shares is 42.37M.
What is Petros Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Petros Pharmaceuticals PE Ratio is 0.00419580 now.
What was Petros Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Petros Pharmaceuticals EPS is 1.43 USD over the trailing 12 months.
Which sector does the Petros Pharmaceuticals company belong to?
The Petros Pharmaceuticals sector is Healthcare.
Petros Pharmaceuticals PTPI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26186.41 USD — |
-0.56
|
6.24B USD — | 25992.55 USD — | 26329.98 USD — | — - | 6.24B USD — |
|
US Tech Health Care
IXHC
US
|
1308.52 USD — |
+1.15
|
— — | 1296.22 USD — | 1310.89 USD — | — - | — — |
- {{ link.label }} {{link}}
